Profile data is unavailable for this security.
About the company
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
- Revenue in USD (TTM)0.00
- Net income in USD-8.63m
- Incorporated2010
- Employees6.00
- LocationAmpio Pharmaceuticals Inc9800 Mount Pyramid Court, Suite 400ENGLEWOOD 80112United StatesUSA
- Phone+1 (720) 437-6500
- Fax+1 (720) 437-6501
- Websitehttps://ampiopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc | 0.00 | -8.63m | 147.60k | 6.00 | -- | 0.0323 | -- | -- | -11.10 | -11.10 | 0.00 | 4.03 | 0.00 | -- | -- | 0.00 | -89.34 | -72.16 | -109.57 | -84.33 | -- | -- | -- | -- | 2.32 | -- | 0.00 | -- | -- | -- | 47.16 | -- | -- | -- |
| Propanc Biopharma Inc | 0.00 | -2.46m | 184.78k | 1.00 | -- | -- | -- | -- | -0.3033 | -0.3033 | 0.00 | -0.0337 | 0.00 | -- | -- | -- | -2,440.90 | -4,945.87 | -- | -- | -- | -- | -- | -- | -- | -1.70 | -- | -- | -- | -- | -17.63 | -- | -- | -- |
| Black Bird Biotech Inc | 36.33k | -836.14k | 196.81k | 4.00 | -- | -- | -- | 5.42 | -0.0018 | -0.0018 | 0.00005 | -0.0005 | 0.2718 | 0.3178 | 13.31 | 9,082.50 | -625.64 | -433.36 | -- | -- | 27.55 | -- | -2,301.51 | -1,800.06 | 0.0154 | -0.6032 | -- | -- | -20.96 | -- | 8.42 | -- | -- | -- |
| Athersys Inc | 80.00k | -37.51m | 209.84k | 24.00 | -- | -- | -- | 2.62 | -2.03 | -2.03 | 0.004 | -1.36 | 0.0037 | -- | 0.2424 | 3,333.33 | -174.57 | -120.93 | -- | -206.72 | -- | -- | -46,883.75 | -727.72 | -- | -- | -- | -- | -3.43 | 7.51 | 16.58 | -- | 6.85 | -- |
| Gelstat Corp | 1.68m | -1.22m | 210.00k | 2.00 | -- | 0.0287 | -- | 0.125 | -0.0033 | -0.0033 | 0.0046 | 0.014 | 0.3021 | 4.17 | -- | 840,285.00 | -21.96 | -- | -26.29 | -- | 28.99 | -- | -72.69 | -- | 0.3216 | -134.79 | 0.0267 | -- | -66.81 | -- | -60.17 | -- | -- | -- |
Data as of Jun 25 2024. Currency figures normalised to Ampio Pharmaceuticals Inc's reporting currency: US Dollar USD
3.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Virtu Americas LLCas of 31 Mar 2024 | 19.10k | 1.68% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 7.77k | 0.68% |
| Tower Research Capital LLCas of 31 Mar 2024 | 3.54k | 0.31% |
| CVA Family Office LLCas of 31 Mar 2024 | 3.15k | 0.28% |
| UBS Securities LLCas of 31 Mar 2024 | 1.25k | 0.11% |
| Cypress Capital Management LLC (Wyoming)as of 31 Mar 2024 | 461.00 | 0.04% |
| Arbor Point Advisors LLCas of 31 Mar 2024 | 315.00 | 0.03% |
| GHP Investment Advisors, Inc.as of 31 Mar 2024 | 300.00 | 0.03% |
| Sunbelt Securities, Inc.as of 31 Mar 2024 | 206.00 | 0.02% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 101.00 | 0.01% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
